308 related articles for article (PubMed ID: 23907102)
1. Quantitative evaluation of computed high B value diffusion-weighted magnetic resonance imaging of the prostate.
Maas MC; Fütterer JJ; Scheenen TW
Invest Radiol; 2013 Nov; 48(11):779-86. PubMed ID: 23907102
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of Exponential ADC (eADC) and Computed DWI (cDWI) for the Detection of Prostate Cancer.
Sprinkart AM; Marx C; Träber F; Block W; Thomas D; Schild H; Kukuk GM; Mürtz P
Rofo; 2018 Aug; 190(8):758-766. PubMed ID: 30045400
[TBL] [Abstract][Full Text] [Related]
3. High-b-value diffusion-weighted imaging at 3 T to detect prostate cancer: comparisons between b values of 1,000 and 2,000 s/mm2.
Kim CK; Park BK; Kim B
AJR Am J Roentgenol; 2010 Jan; 194(1):W33-7. PubMed ID: 20028888
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of Diffusion Kurtosis Imaging Versus Standard Diffusion Imaging for Detection and Grading of Peripheral Zone Prostate Cancer.
Roethke MC; Kuder TA; Kuru TH; Fenchel M; Hadaschik BA; Laun FB; Schlemmer HP; Stieltjes B
Invest Radiol; 2015 Aug; 50(8):483-9. PubMed ID: 25867657
[TBL] [Abstract][Full Text] [Related]
5. Apparent diffusion coefficient-dependent voxelwise computed diffusion-weighted imaging: An approach for improving SNR and reducing T2 shine-through effects.
Gatidis S; Schmidt H; Martirosian P; Nikolaou K; Schwenzer NF
J Magn Reson Imaging; 2016 Apr; 43(4):824-32. PubMed ID: 26348708
[TBL] [Abstract][Full Text] [Related]
6. Diffusion-weighted MRI of peripheral zone prostate cancer: comparison of tumor apparent diffusion coefficient with Gleason score and percentage of tumor on core biopsy.
Woodfield CA; Tung GA; Grand DJ; Pezzullo JA; Machan JT; Renzulli JF
AJR Am J Roentgenol; 2010 Apr; 194(4):W316-22. PubMed ID: 20308476
[TBL] [Abstract][Full Text] [Related]
7. Apparent diffusion coefficient for prostate cancer imaging: impact of B values.
Peng Y; Jiang Y; Antic T; Sethi I; Schmid-Tannwald C; Eggener S; Oto A
AJR Am J Roentgenol; 2014 Mar; 202(3):W247-53. PubMed ID: 24555621
[TBL] [Abstract][Full Text] [Related]
8. High b-value diffusion-weighted MR imaging of normal brain at 3T.
Cihangiroglu M; Uluğ AM; Firat Z; Bayram A; Kovanlikaya A; Kovanlikaya I
Eur J Radiol; 2009 Mar; 69(3):454-8. PubMed ID: 18162352
[TBL] [Abstract][Full Text] [Related]
9. Diffusion-weighted MR imaging for detection of extrahepatic cholangiocarcinoma.
Cui XY; Chen HW; Cai S; Bao J; Tang QF; Wu LY; Fang XM
Eur J Radiol; 2012 Nov; 81(11):2961-5. PubMed ID: 22285604
[TBL] [Abstract][Full Text] [Related]
10. High-b-value diffusion-weighted MRI for the detection of prostate cancer at 3 T.
Wang X; Qian Y; Liu B; Cao L; Fan Y; Zhang JJ; Yu Y
Clin Radiol; 2014 Nov; 69(11):1165-70. PubMed ID: 25182363
[TBL] [Abstract][Full Text] [Related]
11. Whole-body MRI including diffusion-weighted imaging (DWI) for patients with recurring prostate cancer: technical feasibility and assessment of lesion conspicuity in DWI.
Eiber M; Holzapfel K; Ganter C; Epple K; Metz S; Geinitz H; Kübler H; Gaa J; Rummeny EJ; Beer AJ
J Magn Reson Imaging; 2011 May; 33(5):1160-70. PubMed ID: 21509875
[TBL] [Abstract][Full Text] [Related]
12. Utility of computed diffusion-weighted MRI for predicting aggressiveness of prostate cancer.
Waseda Y; Yoshida S; Takahara T; Kwee TC; Matsuoka Y; Saito K; Kihara K; Fujii Y
J Magn Reson Imaging; 2017 Aug; 46(2):490-496. PubMed ID: 28152258
[TBL] [Abstract][Full Text] [Related]
13. High and ultra-high b-value diffusion-weighted imaging in prostate cancer: a quantitative analysis.
Wetter A; Nensa F; Lipponer C; Guberina N; Olbricht T; Schenck M; Schlosser TW; Gratz M; Lauenstein TC
Acta Radiol; 2015 Aug; 56(8):1009-15. PubMed ID: 25168023
[TBL] [Abstract][Full Text] [Related]
14. High-resolution diffusion-weighted imaging of the prostate.
Medved M; Soylu-Boy FN; Karademir I; Sethi I; Yousuf A; Karczmar GS; Oto A
AJR Am J Roentgenol; 2014 Jul; 203(1):85-90. PubMed ID: 24951199
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the impact of computed high b-value diffusion-weighted imaging on prostate cancer detection.
Verma S; Sarkar S; Young J; Venkataraman R; Yang X; Bhavsar A; Patil N; Donovan J; Gaitonde K
Abdom Radiol (NY); 2016 May; 41(5):934-45. PubMed ID: 27193792
[TBL] [Abstract][Full Text] [Related]
16. 3-T breast diffusion-weighted MRI by echo-planar imaging with spectral spatial excitation or with additional spectral inversion recovery: an in vivo comparison of image quality.
Jacobsen MC; Dogan BE; Adrada BE; Plaxco JS; Wei W; Son JB; Hazle JD; Ma J
J Comput Assist Tomogr; 2015; 39(3):343-8. PubMed ID: 25695868
[TBL] [Abstract][Full Text] [Related]
17. Stimulated-echo diffusion-weighted imaging with moderate b values for the detection of prostate cancer.
Zhang Y; Wells SA; Triche BL; Kelcz F; Hernando D
Eur Radiol; 2020 Jun; 30(6):3236-3244. PubMed ID: 32064561
[TBL] [Abstract][Full Text] [Related]
18. Computed high-b-value high-resolution DWI improves solid lesion detection in IPMN of the pancreas.
Harder FN; Jung E; Weiss K; Graf MM; Kamal O; McTavish S; Van AT; Demir IE; Friess H; Phillip V; Schmid RM; Lohöfer FK; Kaissis GA; Makowski MR; Karampinos DC; Braren RF
Eur Radiol; 2023 Oct; 33(10):6892-6901. PubMed ID: 37133518
[TBL] [Abstract][Full Text] [Related]
19. Deep learning image reconstruction of diffusion-weighted imaging in evaluation of prostate cancer focusing on its clinical implications.
Jeong J; Yeom SK; Choi IY; Cha SH; Han JS; Lee CH; Sung DJ; Choi JW; Bae JH; Choi H; Kim I; Benkert T; Weiland E
Quant Imaging Med Surg; 2024 May; 14(5):3432-3446. PubMed ID: 38720859
[TBL] [Abstract][Full Text] [Related]
20. Prostate cancer: comparison of tumor visibility on trace diffusion-weighted images and the apparent diffusion coefficient map.
Rosenkrantz AB; Kong X; Niver BE; Berkman DS; Melamed J; Babb JS; Taneja SS
AJR Am J Roentgenol; 2011 Jan; 196(1):123-9. PubMed ID: 21178056
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
